Koyfin Home > Directory > Health Care > Kura Oncology > Net Debt / (EBITDA-CAPEX)

Kura Oncology Net Debt / (EBITDA-CAPEX) Chart (KURA)

Kura Oncology annual/quarterly Net Debt / (EBITDA-CAPEX) from 2015 to 2020.
  • Kura Oncology Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $4m a 9.17% increase of 0m year over year
  • Kura Oncology Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $4m a 9.65% increase of 0m year over year
  • Kura Oncology Annual Net Debt / (EBITDA-CAPEX) for 2019 was $3m a 20.40% increase of 1m from 2018
  • Kura Oncology Annual Net Debt / (EBITDA-CAPEX) for 2018 was $3m a 12.48% increase of 0m from 2017
  • Kura Oncology Annual Net Debt / (EBITDA-CAPEX) for 2017 was $2m a 10.61% increase of 0m from 2016
Other Ratios Metrics:
  • Kura Oncology Total Debt / Capital for the quarter ending September 09, 2018 was $3m a -135.60% decrease of -5m year over year
  • Kura Oncology Other Liabilities for the quarter ending December 12, 2018 was $0m a -59.86% decrease of 0m year over year
  • Kura Oncology Total Debt / Equity for the quarter ending September 09, 2018 was $4m a -147.66% decrease of -5m year over year
View Chart On Koyfin

Quarterly KURA Net Debt / (EBITDA-CAPEX) Data

06/2020$4m
03/2020$3m
12/2019$3m
09/2019$3m
06/2019$4m
03/2019$3m
12/2018$3m
09/2018$3m
06/2018$2m
03/2018$2m

Annual KURA Net Debt / (EBITDA-CAPEX) Data

2019$3m
2018$3m
2017$2m
2016$2m
2015$4m
2014$0m